Secondary organising pneumonia associated to COVID-19 infection in patients with central nervous system inflammatory demyelinating diseases treated with anti-CD20 therapies.
Saved in:
| Title: | Secondary organising pneumonia associated to COVID-19 infection in patients with central nervous system inflammatory demyelinating diseases treated with anti-CD20 therapies. |
|---|---|
| Authors: | Carvajal R; Department of Neurology-Neuroimmunology, Vall Hebron University Hospital and Multiple Sclerosis Centre of Catalonia (Cemcat) & Universitat Autònoma de Barcelona, Barcelona, Spain., Rodríguez-Acevedo B; Department of Neurology-Neuroimmunology, Vall Hebron University Hospital and Multiple Sclerosis Centre of Catalonia (Cemcat) & Universitat Autònoma de Barcelona, Barcelona, Spain., García-Vasco L; Department of Neurology, Hospital Clínico San Carlos, IdISSC, Madrid, Spain., Zabalza A; Department of Neurology-Neuroimmunology, Vall Hebron University Hospital and Multiple Sclerosis Centre of Catalonia (Cemcat) & Universitat Autònoma de Barcelona, Barcelona, Spain., Ariño H; Department of Neurology-Neuroimmunology, Vall Hebron University Hospital and Multiple Sclerosis Centre of Catalonia (Cemcat) & Universitat Autònoma de Barcelona, Barcelona, Spain., Bollo L; Department of Neurology-Neuroimmunology, Vall Hebron University Hospital and Multiple Sclerosis Centre of Catalonia (Cemcat) & Universitat Autònoma de Barcelona, Barcelona, Spain., Cabello-Clotet N; Department of Internal Medicine-Infectious Diseases, Hospital Clínico San Carlos-IdISSC, CIBERINFEC-ISIII, Universidad Complutense, Madrid, Spain., Castilló J; Department of Neurology-Neuroimmunology, Vall Hebron University Hospital and Multiple Sclerosis Centre of Catalonia (Cemcat) & Universitat Autònoma de Barcelona, Barcelona, Spain., Cobo-Calvo Á; Department of Neurology-Neuroimmunology, Vall Hebron University Hospital and Multiple Sclerosis Centre of Catalonia (Cemcat) & Universitat Autònoma de Barcelona, Barcelona, Spain., Comabella M; Department of Neurology-Neuroimmunology, Vall Hebron University Hospital and Multiple Sclerosis Centre of Catalonia (Cemcat) & Universitat Autònoma de Barcelona, Barcelona, Spain., Falcó-Roget A; Department of Infectious Diseases, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain., Galán I; Department of Neurology-Neuroimmunology, Vall Hebron University Hospital and Multiple Sclerosis Centre of Catalonia (Cemcat) & Universitat Autònoma de Barcelona, Barcelona, Spain., García-Sarreón A; Department of Neurology-Neuroimmunology, Vall Hebron University Hospital and Multiple Sclerosis Centre of Catalonia (Cemcat) & Universitat Autònoma de Barcelona, Barcelona, Spain., Gómez-Estévez I; Department of Neurology, Hospital Clínico San Carlos, IdISSC, Madrid, Spain., Granados G; Department of Pneumology, Interstitial Lung Disease Unit, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain., La Puma D; Department of Neurology-Neuroimmunology, Vall Hebron University Hospital and Multiple Sclerosis Centre of Catalonia (Cemcat) & Universitat Autònoma de Barcelona, Barcelona, Spain., Mato Chain G; Department of Preventive Medicine, Hospital Clínico San Carlos, Madrid, Spain., Midaglia L; Department of Neurology-Neuroimmunology, Vall Hebron University Hospital and Multiple Sclerosis Centre of Catalonia (Cemcat) & Universitat Autònoma de Barcelona, Barcelona, Spain., Nieto-García A; Department of Pneumology, Hospital Clínico San Carlos, Madrid, Spain., Otero-Romero S; Neurology Department, Vall Hebron University Hospital and Multiple Sclerosis Centre of Catalonia (Cemcat) & Universitat Autònoma de Barcelona, Barcelona, Spain.; Department of Preventive Medicine and Epidemiology, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain., Pappolla A; Department of Neurology-Neuroimmunology, Vall Hebron University Hospital and Multiple Sclerosis Centre of Catalonia (Cemcat) & Universitat Autònoma de Barcelona, Barcelona, Spain., Rodriguez M; Department of Neurology-Neuroimmunology, Vall Hebron University Hospital and Multiple Sclerosis Centre of Catalonia (Cemcat) & Universitat Autònoma de Barcelona, Barcelona, Spain., Sansano I; Department of Patology, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain., Río J; Department of Neurology-Neuroimmunology, Vall Hebron University Hospital and Multiple Sclerosis Centre of Catalonia (Cemcat) & Universitat Autònoma de Barcelona, Barcelona, Spain., Tagliani P; Department of Neurology-Neuroimmunology, Vall Hebron University Hospital and Multiple Sclerosis Centre of Catalonia (Cemcat) & Universitat Autònoma de Barcelona, Barcelona, Spain., Tur C; Department of Neurology-Neuroimmunology, Vall Hebron University Hospital and Multiple Sclerosis Centre of Catalonia (Cemcat) & Universitat Autònoma de Barcelona, Barcelona, Spain., Vidal-Jordana Á; Department of Neurology-Neuroimmunology, Vall Hebron University Hospital and Multiple Sclerosis Centre of Catalonia (Cemcat) & Universitat Autònoma de Barcelona, Barcelona, Spain., Vilaseca A; Department of Neurology-Neuroimmunology, Vall Hebron University Hospital and Multiple Sclerosis Centre of Catalonia (Cemcat) & Universitat Autònoma de Barcelona, Barcelona, Spain., Villar A; Department of Pneumology, Interstitial Lung Disease Unit, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain., Sastre-Garriga J; Department of Neurology-Neuroimmunology, Vall Hebron University Hospital and Multiple Sclerosis Centre of Catalonia (Cemcat) & Universitat Autònoma de Barcelona, Barcelona, Spain., Oreja-Guevara C; Department of Neurology, Hospital Clínico San Carlos, IdISSC, Madrid, Spain.; Medicine department, Universidad Complutense, Madrid, Spain., Tintoré M; Neurology Department, Vall Hebron University Hospital and Multiple Sclerosis Centre of Catalonia (Cemcat) & Universitat Autònoma de Barcelona, Barcelona, Spain.; Universitat de Vic-Universitat Central de Catalunya (UVic-UCC), Barcelona, Spain., Montalban X; Neurology Department, Vall Hebron University Hospital and Multiple Sclerosis Centre of Catalonia (Cemcat) & Universitat Autònoma de Barcelona, Barcelona, Spain.; Universitat de Vic-Universitat Central de Catalunya (UVic-UCC), Barcelona, Spain., Arrambide G; Department of Neurology-Neuroimmunology, Vall Hebron University Hospital and Multiple Sclerosis Centre of Catalonia (Cemcat) & Universitat Autònoma de Barcelona, Barcelona, Spain. |
| Source: | Multiple sclerosis (Houndmills, Basingstoke, England) [Mult Scler] 2024 Dec; Vol. 30 (14), pp. 1788-1801. Date of Electronic Publication: 2024 Nov 09. |
| Publication Type: | Journal Article; Multicenter Study |
| Journal Info: | Publisher: SAGE Publications Country of Publication: England NLM ID: 9509185 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-0970 (Electronic) Linking ISSN: 13524585 NLM ISO Abbreviation: Mult Scler Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1477-0970 |
|---|---|
| DOI: | 10.1177/13524585241297038 |
